Table 2 Disease duration and medication in the Turku cohort.

From: Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis

Illness duration (mo)

Antipsychotic medication (p.o.)

CPZ eqv DDD (Leucht)

BPRS positive sum**

Diagnosis

4

Risperidone 1 mg

60 mg

13

Affective psychosis

2

Aripiprazole 15 mg

300 mg

21

Affective psychosis

6

Risperidone 2 mg

120 mg

13

Schizophrenia*

1

Olanzapine 5 mg

150 mg

31

Affective psychosis

3

Perphenazine 8 mg

80 mg

12

Schizophreniform

22

Aripiprazole 15 mg

300 mg

26

Schizophrenia

2

27

Schizophrenia

3

Aripiprazole 15 mg + olanzapine 10 mg

600 mg

17

Schizophrenia

  1. *Cannabis dependance disorder.
  2. **BPRS, Brief Psychiatric Rating Scale.
  3. Data for each patient listed as separate row.